Tie-2
Catalog No. | Inhibitor Name | Tie-2 | Other |
---|---|---|---|
A10996 | Cabozantinib | *** | VEGFR2/KDR,c-Met,Kit |
A10587 | MGCD-265 | **** | Met,RON,VEGFR2 |
A10932 | Tie2 kinase inhibitor | ** | |
A13456 | AMG-Tie2-1 | **** | |
A10895 | Pexmetinib (ARRY-614) | p38 MAPK | |
A14387 | Altiratinib (DCC2701) |
Notes:
1.Hover mouse over " " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.
-
XL184 free base (Cabozantinib)
Catalog No. A10996 VEGFR inhibitorXL184 free base (Cabozantinib) is a small molecule designed to inhibit multiple receptor tyrosine kinases, specifically MET and VEGFR2. Learn More -
CE-245677
Catalog No. A19377 Tie2 and TrkA/B inhibitorCE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases with a cellular IC50s of 4.7 and 1 nM. Learn More -
MGCD-265 (Glesatinib)
Catalog No. A10587 c-Met inhibitorMGCD265 is a multitargeted tyrosine kinase inhibitor that binds to and inhibits the phosphorylation of several RTKs, including the c-Met receptor (HGFR); the Tek/Tie-2 receptor; VEGFR types 1, 2, and 3; and MST1R. Learn More -
Tie2 kinase inhibitor
Catalog No. A10932 Tie2 kinase inhibitorTie2 kinase inhibitor is a potent and selective Tie2 inhibitor with IC50 of 0.25 μM. Learn More -
AMG-Tie2-1
Catalog No. A13456 Tie-2 inhibitorAMG-Tie2-1 is a highly potent, non-selective inhibitor of Tie-2 (IC50 <1 nM). Learn More -
Altiratinib (DCC2701)
Catalog No. A14387 c-Met/VEGFR inhibitorAltiratinib is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. Learn More -
Pexmetinib (ARRY-614)
Catalog No. A10895 p38 MAPK inhibitorPexmetinib is a potent inhibitor of cytokine synthesis, via the dual inhibition of p38 mitogen-activated protein kinase (MAPK), and Tie2/Tek receptor tyrosine kinase. Learn More